1-O-Acetyl-2,3,5-Tri-O-Benzoyl-β-D-Ribofuranose

6974-32-9

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is mar∏ket-oriented and realizes industrial development through R&D innovation and technology t¥ransformation.

key word:

innovation pharmaceutical

Category:

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large health πindustry finance platform company integrating pharmaceuδtical, intelligent medical, bio pharmaceutical R&D,₽ industrial production and sales.

The chemical reactions involved in the existing products include Fouc÷ault reaction, nitration reaction, sulfonation reaction, hydrog₩enation reaction, fluorination reaction, chlorination reaction, bromination reaction, ☆diazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (≠DPP4) inhibitor developed by Merck. In October 2006, Sitag✔liptin phosphate Januvia was approved by FDA as the first DPP4 inhibito±r for the treatment of type ⅱ diabetes mellitus. The characterisφtics of this drug are that it can stimulate insulin secεretion while reducing hunger without causing weight ga↕in. Hypoglycemia and edema will not occur, and it is suitable for  diabetic patients with poor blood glucose control and frequent h ypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that∏ is market-oriented and realizes industrial develo§pment through R&D innovation and technology transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is o∏ne of the most important products for the treatment of arthritis. It is well tolerated and has a ₽low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptσor antagonists. In clinical application, it has good ther¶apeutic effect on atopic asthma and other types of bronchial asthma, and the markεet prospect is huge. In the major category of asthma drugs, leukotriene receptor antagoni§sts have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that€ is market-oriented and realizes industrial development through R&¶D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the second drug approved by FDA for Alzh¶eimer's disease in the United States. Its treatment reaches the target do se and has low toxic and side effects. It has been widel✘y recognized by our medical community, and good tolerance is its biggest advantage. In Oc±tober 1999, Donepezil was launched in China under the trade name "Aricept<", which is the main chemical drug against Alzheimer's disease. At present, CFDA< has approved a number of domestic enterprises to produce donepez↕il preparations, the main dosage forms are tablets, capsules, dispersive tablets, oral disinte↕grating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Ap™ixaban (Eliquis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa inhibitor,≠ was approved for use in the 27 EU member states. The world's first drug approved to prevent venεous thromboembolism (VTE) in adult patients undergoing elective hip or knee replacement. ₹From June 2019 to June 2020, the annual sales of apixaban products overseas reached about $15.4 ↔billion, with a year-on-year growth of nearly 32%, and the API consumption reached about 2®3,960 kg, with a year-on-year growth of about 28%. Compared with itφs main competitor, Rivaroxaban, the drug's annual overseas sales are about $4.5 bλillion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharma→ceutical enterprise that is market-oriented and reaαlizes industrial development through R&D innovation and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and mεanufactured by Genzyme. On December 29, 2004, it was approved by FDA for the treatment of rφefractory or relapsed acute lymphoblastic leukemia (ALL) in children.♣

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterpris♥e that is market-oriented and realizes industrial development through R&D inn ovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If you need other services, E-mail: 2880705932@qq.com